1Catalona WJ, Smith DS, Ratliff TL, et al. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med, 1991, 324:1156-1161.
2Harada M, Nemoto R, Uchida K, et al. Histopathological comparison of prostatic adenocarcinoma in Janpan and the United States. J Japanese Urolology, 1993, 84: 1110-1118.
3Humphrey PA, Keetch DW, Smith DS, et al. Prospective characterization of pathological feature of prostatic carcinomas detected via serum prostate specific antigen based screening. J Urol, 1996, 155: 816-820.
4Bostick DG, Dundore PA, eds. Biopsy pathology of the prostate. New York: Chapman & Hall Medical, 1997.141-163.
5Rigley JR, Bullock M, and Amin M. Small glandular patterns in the prostate: Differential diagnosis of small acinar carcinoma. In: Foster CS and Bostwick DG, eds. Pathology of prostate. Philadelphia: Sauders Company, 1998.126-155.
6Shirley SE, Escoffery CT, Sargeant LA, et al. Clinicopathological features of prostate cancer in Jamaican men. BJU Int, 2002, 89: 390-395.
7Shizuka O, Satoh T, Kobayashi S, et al. Mass screening for prostate cancer in Nagano. Hinyokika Kiyo, 2001, 47: 769-772.
8Catalona WJ, Richie JP, Ahmann FR. et al. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6630 men. J Urol, 1994, 151: 1283-1290.
